SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (9926)10/21/1997 3:58:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Andy, Reread the Lehman report. It says "Ligand has an option to take a product from Lilly (which will likely see FDA approval next year) and sell it themselves."



To: Andrew H who wrote (9926)10/21/1997 4:26:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Andy, The rec does say "seek" approval next year which I still think indicates that they are trying to get it approved for next year.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News